nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—PDE8B—ganglion—brain cancer	0.0387	0.0775	CbGeAlD
Flavoxate—PDE4C—ganglion—brain cancer	0.0359	0.0718	CbGeAlD
Flavoxate—Raloxifene—ESR2—brain cancer	0.0168	1	CrCbGaD
Flavoxate—PDE4C—brainstem—brain cancer	0.0156	0.0312	CbGeAlD
Flavoxate—PDE8B—telencephalon—brain cancer	0.0149	0.0299	CbGeAlD
Flavoxate—PDE4C—telencephalon—brain cancer	0.0138	0.0277	CbGeAlD
Flavoxate—PDE7A—endocrine gland—brain cancer	0.0135	0.0271	CbGeAlD
Flavoxate—PDE8A—telencephalon—brain cancer	0.0134	0.0269	CbGeAlD
Flavoxate—PDE7A—head—brain cancer	0.0134	0.0268	CbGeAlD
Flavoxate—PDE8B—gonad—brain cancer	0.0125	0.025	CbGeAlD
Flavoxate—PDE7A—central nervous system—brain cancer	0.0122	0.0244	CbGeAlD
Flavoxate—PDE4D—telencephalon—brain cancer	0.0122	0.0244	CbGeAlD
Flavoxate—PDE7B—head—brain cancer	0.0117	0.0234	CbGeAlD
Flavoxate—PDE8A—pituitary gland—brain cancer	0.0109	0.0219	CbGeAlD
Flavoxate—PDE4A—telencephalon—brain cancer	0.0108	0.0216	CbGeAlD
Flavoxate—PDE8B—midbrain—brain cancer	0.0107	0.0215	CbGeAlD
Flavoxate—PDE7B—central nervous system—brain cancer	0.0107	0.0214	CbGeAlD
Flavoxate—PDE8A—medulla oblongata—brain cancer	0.0106	0.0211	CbGeAlD
Flavoxate—PDE4C—midbrain—brain cancer	0.00993	0.0199	CbGeAlD
Flavoxate—PDE7A—brain—brain cancer	0.00969	0.0194	CbGeAlD
Flavoxate—PDE8A—midbrain—brain cancer	0.00965	0.0193	CbGeAlD
Flavoxate—PDE8B—endocrine gland—brain cancer	0.00942	0.0189	CbGeAlD
Flavoxate—PDE8A—spinal cord—brain cancer	0.00942	0.0189	CbGeAlD
Flavoxate—PDE8B—head—brain cancer	0.0093	0.0186	CbGeAlD
Flavoxate—PDE4C—head—brain cancer	0.00861	0.0172	CbGeAlD
Flavoxate—PDE8B—central nervous system—brain cancer	0.00849	0.017	CbGeAlD
Flavoxate—PDE7B—brain—brain cancer	0.00847	0.017	CbGeAlD
Flavoxate—PDE8B—cerebellum—brain cancer	0.0083	0.0166	CbGeAlD
Flavoxate—PDE4C—central nervous system—brain cancer	0.00786	0.0157	CbGeAlD
Flavoxate—PDE8A—cerebellum—brain cancer	0.00747	0.0149	CbGeAlD
Flavoxate—PDE4D—cerebellum—brain cancer	0.00677	0.0135	CbGeAlD
Flavoxate—PDE8B—brain—brain cancer	0.00674	0.0135	CbGeAlD
Flavoxate—PDE4B—telencephalon—brain cancer	0.00643	0.0129	CbGeAlD
Flavoxate—CHRM2—telencephalon—brain cancer	0.00638	0.0128	CbGeAlD
Flavoxate—PDE4C—brain—brain cancer	0.00624	0.0125	CbGeAlD
Flavoxate—PDE8A—brain—brain cancer	0.00606	0.0121	CbGeAlD
Flavoxate—PDE4A—cerebellum—brain cancer	0.00599	0.012	CbGeAlD
Flavoxate—CHRM1—telencephalon—brain cancer	0.00581	0.0116	CbGeAlD
Flavoxate—PDE4D—brain—brain cancer	0.0055	0.011	CbGeAlD
Flavoxate—PDE4B—gonad—brain cancer	0.00536	0.0107	CbGeAlD
Flavoxate—PDE4B—pituitary gland—brain cancer	0.00523	0.0105	CbGeAlD
Flavoxate—PDE4B—medulla oblongata—brain cancer	0.00505	0.0101	CbGeAlD
Flavoxate—PDE4A—brain—brain cancer	0.00486	0.00974	CbGeAlD
Flavoxate—PDE4B—midbrain—brain cancer	0.00461	0.00924	CbGeAlD
Flavoxate—PDE4B—spinal cord—brain cancer	0.0045	0.00901	CbGeAlD
Flavoxate—PDE4B—endocrine gland—brain cancer	0.00405	0.00811	CbGeAlD
Flavoxate—CHRM2—endocrine gland—brain cancer	0.00403	0.00806	CbGeAlD
Flavoxate—PDE4B—head—brain cancer	0.004	0.00801	CbGeAlD
Flavoxate—CHRM2—head—brain cancer	0.00397	0.00796	CbGeAlD
Flavoxate—CHRM1—endocrine gland—brain cancer	0.00366	0.00734	CbGeAlD
Flavoxate—PDE4B—central nervous system—brain cancer	0.00365	0.00731	CbGeAlD
Flavoxate—CHRM2—central nervous system—brain cancer	0.00363	0.00726	CbGeAlD
Flavoxate—CHRM1—head—brain cancer	0.00362	0.00724	CbGeAlD
Flavoxate—PDE4B—cerebellum—brain cancer	0.00357	0.00715	CbGeAlD
Flavoxate—Eosinophilia—Procarbazine—brain cancer	0.00345	0.0435	CcSEcCtD
Flavoxate—Leukopenia—Lomustine—brain cancer	0.00342	0.0432	CcSEcCtD
Flavoxate—CHRM1—central nervous system—brain cancer	0.0033	0.00661	CbGeAlD
Flavoxate—Drowsiness—Procarbazine—brain cancer	0.0031	0.0392	CcSEcCtD
Flavoxate—PDE4B—brain—brain cancer	0.0029	0.00581	CbGeAlD
Flavoxate—CHRM2—brain—brain cancer	0.00288	0.00577	CbGeAlD
Flavoxate—CHRM1—brain—brain cancer	0.00262	0.00525	CbGeAlD
Flavoxate—Drowsiness—Hydroxyurea—brain cancer	0.0024	0.0303	CcSEcCtD
Flavoxate—Tension—Procarbazine—brain cancer	0.00238	0.03	CcSEcCtD
Flavoxate—Nervousness—Procarbazine—brain cancer	0.00236	0.0297	CcSEcCtD
Flavoxate—Leukopenia—Procarbazine—brain cancer	0.00217	0.0274	CcSEcCtD
Flavoxate—Dry mouth—Procarbazine—brain cancer	0.00202	0.0255	CcSEcCtD
Flavoxate—Confusional state—Procarbazine—brain cancer	0.002	0.0252	CcSEcCtD
Flavoxate—Vomiting—Lomustine—brain cancer	0.00198	0.025	CcSEcCtD
Flavoxate—Tachycardia—Procarbazine—brain cancer	0.00193	0.0244	CcSEcCtD
Flavoxate—Nausea—Lomustine—brain cancer	0.00185	0.0234	CcSEcCtD
Flavoxate—Somnolence—Procarbazine—brain cancer	0.00176	0.0222	CcSEcCtD
Flavoxate—Leukopenia—Hydroxyurea—brain cancer	0.00168	0.0212	CcSEcCtD
Flavoxate—Feeling abnormal—Procarbazine—brain cancer	0.00163	0.0206	CcSEcCtD
Flavoxate—Urticaria—Procarbazine—brain cancer	0.00157	0.0198	CcSEcCtD
Flavoxate—Skin disorder—Hydroxyurea—brain cancer	0.00149	0.0188	CcSEcCtD
Flavoxate—Vision blurred—Carmustine—brain cancer	0.00143	0.018	CcSEcCtD
Flavoxate—Vision blurred—Temozolomide—brain cancer	0.00138	0.0174	CcSEcCtD
Flavoxate—Somnolence—Hydroxyurea—brain cancer	0.00136	0.0172	CcSEcCtD
Flavoxate—Leukopenia—Carmustine—brain cancer	0.00136	0.0171	CcSEcCtD
Flavoxate—Vertigo—Temozolomide—brain cancer	0.00132	0.0166	CcSEcCtD
Flavoxate—Leukopenia—Temozolomide—brain cancer	0.00131	0.0166	CcSEcCtD
Flavoxate—Palpitations—Temozolomide—brain cancer	0.0013	0.0164	CcSEcCtD
Flavoxate—Feeling abnormal—Hydroxyurea—brain cancer	0.00126	0.0159	CcSEcCtD
Flavoxate—Vomiting—Procarbazine—brain cancer	0.00126	0.0159	CcSEcCtD
Flavoxate—Confusional state—Carmustine—brain cancer	0.00125	0.0158	CcSEcCtD
Flavoxate—Headache—Procarbazine—brain cancer	0.00124	0.0157	CcSEcCtD
Flavoxate—Dry mouth—Temozolomide—brain cancer	0.00122	0.0154	CcSEcCtD
Flavoxate—Tachycardia—Carmustine—brain cancer	0.00121	0.0153	CcSEcCtD
Flavoxate—Confusional state—Temozolomide—brain cancer	0.00121	0.0152	CcSEcCtD
Flavoxate—Nausea—Procarbazine—brain cancer	0.00118	0.0148	CcSEcCtD
Flavoxate—Skin disorder—Temozolomide—brain cancer	0.00116	0.0147	CcSEcCtD
Flavoxate—Somnolence—Carmustine—brain cancer	0.0011	0.0139	CcSEcCtD
Flavoxate—Somnolence—Temozolomide—brain cancer	0.00106	0.0134	CcSEcCtD
Flavoxate—Vertigo—Etoposide—brain cancer	0.00105	0.0133	CcSEcCtD
Flavoxate—Leukopenia—Etoposide—brain cancer	0.00105	0.0133	CcSEcCtD
Flavoxate—Feeling abnormal—Carmustine—brain cancer	0.00102	0.0129	CcSEcCtD
Flavoxate—Feeling abnormal—Temozolomide—brain cancer	0.000987	0.0124	CcSEcCtD
Flavoxate—Vomiting—Hydroxyurea—brain cancer	0.000974	0.0123	CcSEcCtD
Flavoxate—Confusional state—Etoposide—brain cancer	0.000966	0.0122	CcSEcCtD
Flavoxate—Headache—Hydroxyurea—brain cancer	0.00096	0.0121	CcSEcCtD
Flavoxate—Urticaria—Temozolomide—brain cancer	0.000951	0.012	CcSEcCtD
Flavoxate—Tachycardia—Etoposide—brain cancer	0.000935	0.0118	CcSEcCtD
Flavoxate—Skin disorder—Etoposide—brain cancer	0.000931	0.0117	CcSEcCtD
Flavoxate—Nausea—Hydroxyurea—brain cancer	0.00091	0.0115	CcSEcCtD
Flavoxate—Somnolence—Etoposide—brain cancer	0.000852	0.0107	CcSEcCtD
Flavoxate—Feeling abnormal—Etoposide—brain cancer	0.00079	0.00996	CcSEcCtD
Flavoxate—Vomiting—Carmustine—brain cancer	0.000788	0.00994	CcSEcCtD
Flavoxate—Headache—Carmustine—brain cancer	0.000776	0.00979	CcSEcCtD
Flavoxate—Vomiting—Temozolomide—brain cancer	0.000761	0.0096	CcSEcCtD
Flavoxate—Urticaria—Etoposide—brain cancer	0.000761	0.0096	CcSEcCtD
Flavoxate—Headache—Temozolomide—brain cancer	0.00075	0.00946	CcSEcCtD
Flavoxate—Nausea—Carmustine—brain cancer	0.000736	0.00928	CcSEcCtD
Flavoxate—Nausea—Temozolomide—brain cancer	0.000711	0.00897	CcSEcCtD
Flavoxate—Vomiting—Etoposide—brain cancer	0.000609	0.00768	CcSEcCtD
Flavoxate—Headache—Etoposide—brain cancer	0.0006	0.00757	CcSEcCtD
Flavoxate—Nausea—Etoposide—brain cancer	0.000569	0.00718	CcSEcCtD
Flavoxate—CHRM1—Signaling by GPCR—ABR—brain cancer	0.00033	0.000817	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—DTX2—brain cancer	0.000328	0.000811	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TRPC6—brain cancer	0.000327	0.000808	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—IL2—brain cancer	0.000326	0.000807	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—ABR—brain cancer	0.000326	0.000806	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—DTX2—brain cancer	0.000324	0.000801	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—SHH—brain cancer	0.000322	0.000797	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PTCH1—brain cancer	0.000321	0.000794	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—SMO—brain cancer	0.000321	0.000794	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TRPC6—brain cancer	0.000311	0.000769	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IRS2—brain cancer	0.00031	0.000767	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PTCH1—brain cancer	0.000306	0.000756	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—SMO—brain cancer	0.000306	0.000756	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—PIK3CG—brain cancer	0.000302	0.000747	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—EGFR—brain cancer	0.000301	0.000745	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—EGFR—brain cancer	0.000301	0.000745	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—SHH—brain cancer	0.000298	0.000738	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000298	0.000737	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NOTCH2—brain cancer	0.000295	0.000729	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—APC—brain cancer	0.000295	0.000728	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—PIK3CG—brain cancer	0.000295	0.000728	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—PIK3CG—brain cancer	0.00029	0.000716	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TRPC6—brain cancer	0.000288	0.000711	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—SMO—brain cancer	0.000283	0.000699	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PTCH1—brain cancer	0.000283	0.000699	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—VAV1—brain cancer	0.000281	0.000695	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—PIK3CG—brain cancer	0.000276	0.000682	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—PIK3CG—brain cancer	0.000274	0.000677	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—APC—brain cancer	0.000274	0.000677	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—EGFR—brain cancer	0.000268	0.000664	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—PIK3CG—brain cancer	0.000263	0.00065	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000262	0.000649	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—RELA—brain cancer	0.000258	0.000639	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—RELA—brain cancer	0.000258	0.000639	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NOTCH2—brain cancer	0.000257	0.000635	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—ERBB2—brain cancer	0.000257	0.000635	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—ERBB2—brain cancer	0.000257	0.000635	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—PIK3CG—brain cancer	0.000255	0.000631	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—PIK3CG—brain cancer	0.00025	0.000619	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—EGFR—brain cancer	0.00025	0.000617	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PTCH2—brain cancer	0.000249	0.000615	CbGpPWpGaD
Flavoxate—CHRM1—Regulation of Actin Cytoskeleton—EGFR—brain cancer	0.000248	0.000613	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PTCH2—brain cancer	0.000245	0.000607	CbGpPWpGaD
Flavoxate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—brain cancer	0.000245	0.000606	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—VAV1—brain cancer	0.000245	0.000605	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NOTCH2—brain cancer	0.000244	0.000604	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—HES1—brain cancer	0.000242	0.000598	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HES5—brain cancer	0.000241	0.000596	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HES5—brain cancer	0.000238	0.000588	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—IL2—brain cancer	0.000234	0.000579	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—STRADA—brain cancer	0.000234	0.000578	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—VAV1—brain cancer	0.000233	0.000576	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—IL2—brain cancer	0.000233	0.000575	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—IL2—brain cancer	0.000233	0.000575	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—PIK3CG—brain cancer	0.000232	0.000573	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—STRADA—brain cancer	0.000231	0.000571	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—TRPC6—brain cancer	0.00023	0.000569	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—RELA—brain cancer	0.00023	0.000569	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PDGFRA—brain cancer	0.00023	0.000569	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—ERBB2—brain cancer	0.000229	0.000566	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—TRPC6—brain cancer	0.000227	0.000562	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—CCND1—brain cancer	0.000227	0.000561	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—CCND1—brain cancer	0.000227	0.000561	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NOTCH2—brain cancer	0.000226	0.000559	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—CTNNB1—brain cancer	0.000225	0.000555	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—CTNNB1—brain cancer	0.000225	0.000555	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—SPP1—brain cancer	0.000223	0.000553	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—SHH—brain cancer	0.000217	0.000536	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—VAV1—brain cancer	0.000216	0.000533	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—SHH—brain cancer	0.000214	0.000529	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—RELA—brain cancer	0.000214	0.000529	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—ERBB2—brain cancer	0.000213	0.000526	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—IL2—brain cancer	0.000213	0.000526	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HES1—brain cancer	0.00021	0.00052	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—TRPC6—brain cancer	0.000209	0.000517	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IL2—brain cancer	0.000207	0.000513	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—TRPC6—brain cancer	0.000206	0.00051	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—SMO—brain cancer	0.000206	0.000508	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PTCH1—brain cancer	0.000206	0.000508	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—IL2—brain cancer	0.000204	0.000504	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PTCH1—brain cancer	0.000203	0.000502	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—SMO—brain cancer	0.000203	0.000502	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IRS2—brain cancer	0.000202	0.0005	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—CCND1—brain cancer	0.000202	0.0005	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PDGFRA—brain cancer	0.0002	0.000495	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HES1—brain cancer	0.0002	0.000495	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—CTNNB1—brain cancer	0.0002	0.000495	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—VEGFA—brain cancer	0.000198	0.000489	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—VEGFA—brain cancer	0.000198	0.000489	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—STAT3—brain cancer	0.000196	0.000484	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—STAT3—brain cancer	0.000196	0.000484	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ABR—brain cancer	0.000195	0.000483	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—SPP1—brain cancer	0.000195	0.000481	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—IL2—brain cancer	0.000194	0.00048	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IL2—brain cancer	0.000193	0.000477	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ABR—brain cancer	0.000193	0.000476	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PDGFRA—brain cancer	0.000191	0.000472	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GLI2—brain cancer	0.000188	0.000466	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CCND1—brain cancer	0.000188	0.000465	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CTNNB1—brain cancer	0.000186	0.00046	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GLI2—brain cancer	0.000186	0.00046	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HES1—brain cancer	0.000185	0.000458	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—SPP1—brain cancer	0.000185	0.000458	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—IL2—brain cancer	0.000185	0.000458	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.000185	0.000458	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—MYC—brain cancer	0.000182	0.00045	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—MYC—brain cancer	0.000182	0.00045	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—IL2—brain cancer	0.00018	0.000444	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—APC—brain cancer	0.000178	0.000441	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PIK3CG—brain cancer	0.000178	0.000441	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—EGFR—brain cancer	0.000178	0.00044	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—EGFR—brain cancer	0.000178	0.00044	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GLI1—brain cancer	0.000177	0.000438	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PDGFRA—brain cancer	0.000176	0.000436	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—VEGFA—brain cancer	0.000176	0.000436	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—IL2—brain cancer	0.000176	0.000436	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IRS2—brain cancer	0.000176	0.000435	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GLI1—brain cancer	0.000175	0.000433	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—STAT3—brain cancer	0.000174	0.000431	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—VAV1—brain cancer	0.000173	0.000427	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—SPP1—brain cancer	0.000171	0.000424	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—VAV1—brain cancer	0.00017	0.000421	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SUFU—brain cancer	0.000168	0.000415	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IRS2—brain cancer	0.000167	0.000414	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SUFU—brain cancer	0.000166	0.00041	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—TP53—brain cancer	0.000164	0.000405	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—VEGFA—brain cancer	0.000164	0.000405	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—IL2—brain cancer	0.000163	0.000403	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—EGFR—brain cancer	0.000163	0.000402	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—STAT3—brain cancer	0.000162	0.000401	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—MYC—brain cancer	0.000162	0.000401	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GFAP—brain cancer	0.000162	0.000401	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GFAP—brain cancer	0.00016	0.000396	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—EGFR—brain cancer	0.000159	0.000392	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—VAV1—brain cancer	0.000157	0.000387	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—APC—brain cancer	0.000155	0.000384	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PIK3CG—brain cancer	0.000155	0.000384	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IRS2—brain cancer	0.000155	0.000383	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—VAV1—brain cancer	0.000155	0.000382	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HEY1—brain cancer	0.000154	0.00038	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HEY1—brain cancer	0.000152	0.000375	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—MYC—brain cancer	0.000151	0.000373	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—DLL1—brain cancer	0.000151	0.000373	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TP53—brain cancer	0.000149	0.000369	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TP53—brain cancer	0.000149	0.000369	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—DLL1—brain cancer	0.000149	0.000368	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PIK3CG—brain cancer	0.000148	0.000366	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—APC—brain cancer	0.000148	0.000366	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—EGFR—brain cancer	0.000147	0.000364	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—EGFR—brain cancer	0.000142	0.00035	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—RELA—brain cancer	0.000139	0.000345	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—ERBB2—brain cancer	0.000139	0.000343	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PIK3CG—brain cancer	0.000137	0.000338	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—APC—brain cancer	0.000137	0.000338	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—EGFR—brain cancer	0.000135	0.000333	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TP53—brain cancer	0.000133	0.000329	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SHH—brain cancer	0.000128	0.000317	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SHH—brain cancer	0.000126	0.000313	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL2—brain cancer	0.000126	0.000311	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—EGFR—brain cancer	0.000125	0.000308	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TP53—brain cancer	0.000124	0.000306	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TRPC6—brain cancer	0.000124	0.000305	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CCND1—brain cancer	0.000122	0.000303	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TRPC6—brain cancer	0.000122	0.000302	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SMO—brain cancer	0.000121	0.0003	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PTCH1—brain cancer	0.000121	0.0003	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—RELA—brain cancer	0.000121	0.0003	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CTNNB1—brain cancer	0.000121	0.0003	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—ERBB2—brain cancer	0.000121	0.000298	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SMO—brain cancer	0.00012	0.000296	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PTCH1—brain cancer	0.00012	0.000296	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—RELA—brain cancer	0.000116	0.000286	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—ERBB2—brain cancer	0.000115	0.000284	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PIK3CG—brain cancer	0.00011	0.000271	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL2—brain cancer	0.000109	0.00027	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PIK3CG—brain cancer	0.000108	0.000267	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—RELA—brain cancer	0.000107	0.000264	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—VEGFA—brain cancer	0.000107	0.000264	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CCND1—brain cancer	0.000107	0.000264	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ERBB2—brain cancer	0.000106	0.000263	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—STAT3—brain cancer	0.000106	0.000261	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CTNNB1—brain cancer	0.000106	0.000261	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL2—brain cancer	0.000104	0.000257	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CCND1—brain cancer	0.000101	0.000251	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CTNNB1—brain cancer	0.0001	0.000248	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PIK3CG—brain cancer	9.95e-05	0.000246	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PIK3CG—brain cancer	9.82e-05	0.000243	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MYC—brain cancer	9.82e-05	0.000243	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NOTCH2—brain cancer	9.71e-05	0.00024	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL2—brain cancer	9.63e-05	0.000238	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—EGFR—brain cancer	9.61e-05	0.000238	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NOTCH2—brain cancer	9.58e-05	0.000237	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CCND1—brain cancer	9.39e-05	0.000232	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CTNNB1—brain cancer	9.3e-05	0.00023	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—VEGFA—brain cancer	9.29e-05	0.00023	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—VAV1—brain cancer	9.26e-05	0.000229	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—STAT3—brain cancer	9.2e-05	0.000227	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—VAV1—brain cancer	9.14e-05	0.000226	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—VEGFA—brain cancer	8.84e-05	0.000219	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—STAT3—brain cancer	8.76e-05	0.000217	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MYC—brain cancer	8.55e-05	0.000211	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—EGFR—brain cancer	8.36e-05	0.000207	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—VEGFA—brain cancer	8.18e-05	0.000202	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MYC—brain cancer	8.14e-05	0.000201	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—STAT3—brain cancer	8.1e-05	0.0002	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TP53—brain cancer	8.07e-05	0.000199	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HES1—brain cancer	7.96e-05	0.000197	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—EGFR—brain cancer	7.96e-05	0.000197	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HES1—brain cancer	7.86e-05	0.000194	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—IL2—brain cancer	7.71e-05	0.000191	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—IL2—brain cancer	7.61e-05	0.000188	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PDGFRA—brain cancer	7.58e-05	0.000187	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MYC—brain cancer	7.53e-05	0.000186	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PDGFRA—brain cancer	7.48e-05	0.000185	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—EGFR—brain cancer	7.36e-05	0.000182	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SPP1—brain cancer	7.36e-05	0.000182	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SPP1—brain cancer	7.26e-05	0.00018	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TP53—brain cancer	7.02e-05	0.000174	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL2—brain cancer	7e-05	0.000173	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL2—brain cancer	6.91e-05	0.000171	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TP53—brain cancer	6.68e-05	0.000165	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IRS2—brain cancer	6.65e-05	0.000165	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IRS2—brain cancer	6.57e-05	0.000162	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TP53—brain cancer	6.18e-05	0.000153	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—APC—brain cancer	5.88e-05	0.000145	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PIK3CG—brain cancer	5.88e-05	0.000145	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PIK3CG—brain cancer	5.8e-05	0.000143	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—APC—brain cancer	5.8e-05	0.000143	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—EGFR—brain cancer	5.35e-05	0.000132	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—EGFR—brain cancer	5.29e-05	0.000131	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RELA—brain cancer	4.59e-05	0.000114	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ERBB2—brain cancer	4.56e-05	0.000113	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RELA—brain cancer	4.53e-05	0.000112	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ERBB2—brain cancer	4.5e-05	0.000111	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL2—brain cancer	4.14e-05	0.000102	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL2—brain cancer	4.08e-05	0.000101	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCND1—brain cancer	4.03e-05	9.97e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CTNNB1—brain cancer	3.99e-05	9.87e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCND1—brain cancer	3.98e-05	9.84e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CTNNB1—brain cancer	3.94e-05	9.75e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—VEGFA—brain cancer	3.51e-05	8.69e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—STAT3—brain cancer	3.48e-05	8.61e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—VEGFA—brain cancer	3.47e-05	8.58e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—STAT3—brain cancer	3.44e-05	8.49e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MYC—brain cancer	3.23e-05	8e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MYC—brain cancer	3.19e-05	7.89e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EGFR—brain cancer	3.16e-05	7.82e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EGFR—brain cancer	3.12e-05	7.72e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TP53—brain cancer	2.66e-05	6.57e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TP53—brain cancer	2.62e-05	6.48e-05	CbGpPWpGaD
